Yirui Bio: Net profit in 2021 is expected to increase by 236%-297% year-on-year _ Securities Times Network
Home > News > e company
Yirui Bio: Net profit in 2021 is expected to increase by 236%-297% year-on-year
2022-01-19 19:56
Source: Securities Times e Company
Author: Lee Jae-san
Securities Times · e company
Lee Jae-san
2022-01-19 19:56
Securities Times e company news, Yirui Bio (300942) disclosed its performance forecast on the evening of January 19, and it is expected that the net profit in 2021 will be 220 million yuan to 260 million yuan, a year-on-year increase of 236.16%-297.28%. In the fourth quarter of 2021, affected by the high transmissibility of mutant strains such as Omicron, the global epidemic prevention and control has been upgraded, and the market demand for overseas antigen testing has grown again. The company’s orders and revenue for semi-finished products of new crown antigen detection reagents and supporting solutions have also increased, which has led to a substantial increase in performance.
Disclaimer: Securities Times strives for true and accurate information. The content mentioned in the article is for reference only and does not constitute substantive investment advice. Operational risks are based on this.
4089784
Yirui Bio: Net profit in 2021 is expected to increase by 236%-297% year-on-year
6885
e company
news
1445
Lee Jae-san
2022-01-19